Methycap 10/20/30/40mg MR hard capsules
PDF Leaflet Revision Date: 25 September 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of ADHD in children (6+) and adults.
Dosage (summary)
Starting dose 20 mg once daily; max 60 mg (children), 80 mg (adults).
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly patients
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation.
Key Drug Interactions
- MAO inhibitors
- Alcohol
- Serotonergic medicines
Contraindications
- Hypersensitivity to methylphenidate
- Touretteu2019s syndrome
- Severe depression
- Cardiovascular disorders
Common side effects
- Nervousness
- Insomnia
- Decreased appetite
- Abdominal pain
- Nausea
Counselling Points
- Monitor for psychiatric symptoms
- Avoid alcohol
- Regularly assess growth in children
Serious warnings
- Risk of sudden death in patients with heart problems
- Potential for abuse and dependence
Important Disclaimer
The Methycap 10/20/30/40mg MR hard capsules professional information leaflet below is the property of Pharma Dynamics and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
